Aricept, Donepezil News

A novel drug candidate, J147, is able to reverse memory deficits and improve several aspects of brain function in mice with advanced symptoms of Alzheimer's disease , finds research in BioMed Central's open access journal Alzheimer's Research & Therapy.

Ranbaxy, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo, has paid a $500 million fine and pled guilty to selling adulterated drugs manufactured in India .

A novel drug candidate, J147, is able to reverse memory deficits and improve several aspects of brain function in mice with advanced symptoms of Alzheimer's disease , finds research in BioMed Central's open access journal Alzheimer's Research & Therapy .

Anavex Life Sciences Corp. today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation for a Phase 2a trial of ANAVEX 2-73. Since 1998, the ADDF has granted more than $51 million in venture philanthropy funding to projects with potential viability in the market.

The class of acetylcholinesterase inhibitors , including donepezil, rivastigmine, and galantamine, have similar efficacy profiles in patients with mild to moderate Alzheimer's disease .

Cholinesterase inhibitors and memantine are prescribed to slow the progression dementia.